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Mandibular advancement oral appliance
Systematic review
Clinic-based dentists
s  u  m  m  a  r  y
The  purpose  of this  review  was  to present  the  currently  available  information  on  oral  appliance  (OA)
therapy  for  dentists,  especially  clinic-based  dentists,  to  aid them  in performing  this  treatment  for  the
management  of  symptoms  of obstructive  sleep  apnea  (OSA).  The  clinical  research  evidence  comprised
of  systematic  reviews  concerned  with  the  mandibular  advancement  oral  appliance  (OAm).  Continuous
positive  airway  pressure  (CPAP)  is  superior  to  OA  therapy  in  improving  OSA  symptoms.  It  is  necessary
to  survey  the adherence  of  patients  who  stopped  CPAP  therapy  to OAm  therapy.  There  is little evidence
supporting  the  theory  that  OAm  therapy  prevents  cardiovascular  disease  or improves  prognosis.  There
is  still  room  to investigate  the types  of OAm.  OAm  therapy  has  clear  dental  and  skeletal  side effects
with  long-term  use,  and  these  are  important  for dentists.  However,  a certain  percentage  of patients
discontinue  consultations.  Regarding  consultation  rate  for  follow-up  and  repair/adjustments  of  OAm,
there  are  advantages  for the clinic-based  dentists  treating  OSA  with  OAm.  We  believe that  enhancing
under-graduate  and  post-graduate  education  on  sleep  medicine,  and  establishing  a  specialist  system
could  be  the strategies  for  enabling  the dentists  to  handle  OAm  therapy  in  dental  clinics.
©  2019  The  Authors.  Published  by Elsevier  Ltd on  behalf  of  The  Japanese  Association  for  Dental
Science.  This  is  an  open  access  article  under  the CC BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
1. Introduction
Oral appliance (OA) therapy for obstructive sleep apnea (OSA)
attracted attention in the Western countries in the early 1990s. In
Japan, OA became an accepted treatment option for OSA in the mid-
1990s, and was introduced into the National Health Insurance in
2004. OSA is normally diagnosed by doctors. This is because many
sleep disorders exist as a differential diagnosis. When doctors select
OA as the mode of treatment, they request the dentist to fabri-
cate the device. If the patients report with a referral from a doctor,
they are eligible to receive OA therapy through the National Health
Insurance.
The dentists who collaborate with specialists in sleep medicine
perform OA therapy. These are usually dentists working at general
hospitals or dental hospitals. Dental students in Japan also have
received sufficient education on OA therapy for OSA. Some text-
books on OA therapy for OSA have been published, and scientific
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organizations of sleep dental medicine have been inaugurated in
many countries including Japan. There will now be more oppor-
tunities for clinic-based dentists to handle OA  therapy. Hence,
we reviewed the currently available evidence on OA therapy and
provide the information useful for clinic-based dentists to per-
form OA therapy. In particular, we  have focused on and discussed
the importance of follow-up monitoring. Regarding the type of
OA, mandibular advancement oral appliance (OAm) has been con-
sidered more mainstream. The clinical research evidence used
systematic reviews (SR) on OAm for this study.
2. Review of SRs
2.1. Search results
The primary database used was Medline (via PubMed). No
limits were applied to the year of study, but only studies
published in the English language were included. A thorough
literature search was conducted, and was completed on April
11, 2019. The search strategy used: (”Sleep apnea”[TIAB] OR
“Sleep apnoea” OR S̈leep Apnea Syndromes[̈MeSH] OR “Sleep
https://doi.org/10.1016/j.jdsr.2019.10.002






















Descriptions of included systematic reviews.
First author,
year





Hoekema, 2004 Crit Rev Oral Biol
Med.
Efficacy and side effects of OAm 13 (respectively) OAm therapy is a viable treatment especially for mild to moderate OSA.
Lim,  2006 Cochrane Database
Syst Rev.
Comparison between OAm and other
treatments (daytime sleepiness, AHI)
17 There is increasing evidence suggesting that OAm improves subjective sleepiness and sleep
disordered breathing. CPAP appears to be more effective in improving sleep disordered breathing
than  OAm.
Ahrens,  2010 Am J Orthod
Dentofacial Orthop.
Efficacy of different OAms (the subjective
patient-centered outcome)
14 There is no specific OAm design that most effectively influences the subjectively perceived
treatment efficacy
Ahrens,  2011 Eur J Orthod. Efficacy of different OAms
(polysomnographic indices)
14 There is no specific OAm design that most effectively improves polysomnographic indices
Alsufyani,  2013 Sleep Breath. Changes in the upper airway after therapy 3 on OAm The available published studies provide evidence utilizing CBCT to measure anatomic airway
changes  post surgical and dental appliance treatment for OSA.
Iftikhar,  2013 J Clin Sleep Med. Efficacy of OAm (blood pressure) 7 The pooled estimate shows a favorable effect of OAm on blood pressure.
Okuno,  2014 J Oral Rehabil. Comparison between OAm and CPAP
(AHI, ESS, arousal index lowest SpO2,
SF-36)
5 OAm improves OSA when compared with untreated controls. CPAP appears to be more effective in
improving OSA than OAm.
Guarda-Nardini,
2015
J  Clin Sleep Med. Predictive methods for the efficacy of
OAm
13 The mandibular plane angle and the distance between hyoid bone and mandibular plane were found
to  have a predictive value for OAm effectiveness in OSA patients.
Saffer,  2015 Int Arch
Otorhinolaryngol.
Predictive methods for the efficacy of
OAm
14 It remains unclear which predictive factor can be used with confidence to select patients suitable for
treatment  with OAm.
Bratton,  2015 Lancet Respir Med. Comparison between OAm and CPAP
(ESS) [network meta-analysis]
13 on OAm CPAP seemed to be a more effective treatment than OAm, and had an increasingly larger effect on
more  severe or sleepier OSA patients when compared with inactive controls.
Sharples,  2016 Sleep Med Rev. Comparison between OAm and CPAP
(AHI, ESS)
22 on OAm CPAP is the most clinically effective treatment in reducing AHI in moderate to severe OSA.
Serra-Torres,
2016
Laryngoscope.  Efficacy of different OAms 22 Adjustable and custom-made OAms give better results than fixed and prefabricated appliances.
Monobloc appliances cause more adverse effects.
Okuno,  2016 Sleep Med Rev. Predictive methods for the efficacy of
OAm
17 The predictive accuracy varied depending on the definitions of treatment success used as well as the
type  of index test.
Bartolucci,  2016 Sleep Breath. Efficacy of different amounts of
mandibular advancement
13 The AHI improvement was not proportional to the mandibular advancement increase.
Kastoer,  2016 J Clin Sleep Med. Efficacy of remotely controlled
mandibular positioner
4 Remotely controlled mandibular positioner might be a promising instrument for predicting OAm
treatment  outcome and targeting the degree of mandibular advancement needed.
Kuhn,  2017 Chest. Comparison between OAm and CPAP
(SF-36)
23 CPAP is effective in improving health-related QOL in OSA, and OAm may be just as effective, but
further  RCTs comparing the two treatments are required.
Iftikhar,  2017 Sleep Med. Comparison between OAm and other
treatments (AHI, ESS)
Total 80 CPAP is the most efficacious in complete resolution of sleep apnea and in improving the indices of
saturation  during sleep.
Cammaroto,
2017
Med  Oral Patol Oral
Cir  Bucal.
Comparison between OAm and CPAP
(AHI, ESS, lowest SpO2)
6 CPAP still must be considered the gold standard treatment for OSA and, therefore, OAm may be
included  in the list of alternative options.
Sivaramakrishnan,
2017
J  Indian Prosthodont
Soc.
Efficacy of different OAms 5 The results from this systematic review did not show significant advantages in using titratable
appliances
Schwartz,  2018 Sleep Breath. Comparison between OAm and CPAP
(Sleepiness, AHI, QOL, usage compliance)
12 Though CPAP is significantly more efficient in reducing AHI (moderate quality of evidence), it has a
significantly lower compliance resulting in no differences in QOLwith OAm, and no cognitive or
functional outcomes.
de  Vries, 2018 Sleep Med Rev. Efficacy of OAm (cardiovascular
outcomes)
11 It could be speculated that OAm may lead to a  reduction in long-term cardiovascular morbidity and
mortality in OSA patients.
Gao,  2018 J Formos Med Assoc. Comparison between OAm and other
minimally invasive treatments (AHI, ESS)
Total 89 Considering the effectiveness in  reducing both AHI and ESS, CPAP was ranked the best, followed by
OAm  and positional therapy, while lifestyle modification alone was the least effective intervention.
Chen,  2018 J Oral Maxillofac
Surg.
Changes in the upper airway after therapy
(computational fluid dynamics analysis)
2  on Am In the responders to OAm therapy, the velocity, wall static pressure, and airway resistance of the
upper  airway decreased. In nonresponders to OAm therapy, the wall static pressure and airway
resistance of the upper airway increased.
Araie,  2018 Sleep Med Rev. Side effects of OAm 21 Significant change of OJ, OB, and L1-MP was observed in patients with long-term OA use, while there
were  no significant changes of skeletal indices or mandibular rotation.
Zhang,  2018 Cranio. Comparison between OAm and CPAP
(AHI, lowest SpO2)
14 Even though CPAP can better decrease the severity of OSA, more patients opted for OAm, which
showed better results in severe patients, especially adjustable OAm.
Martins,  2018 Dental Press J
Orthod.
Side effects of OAm 6 The limited available evidence suggests that OAm therapy for snoring and OSA results in changes in
craniofacial morphology that are predominantly dental in nature, especially on a long-term basis.
Bartolucci,  2019 Eur J Orthod. Side effects of OAm 6 OAm therapy produces time-related dental and skeletal side effects.
AHI: apnea hypopnea index, CBCT: cone beam computed tomography, CPAP: nasal continuous positive airway pressure, ESS: Epworth Sleepiness Scale, OAm: mandibular advancement oral appliance, OSA: obstructive sleep
apnea  (including obstructive sleep apnea-hypopnea syndrome), OJ: over jet, OB: over bite, QOL: quality of life, RCT: randomized controlled trial.
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apnea syndrome”[TIAB] OR “Sleep apnoea syndrome”[TIAB] OR
“Sleep apnea hypopnea syndrome”[TIAB] “Sleep apnea, Obstruc-
tive”[MeSH] OR “Obstructive sleep apnea”[TIAB] OR “Obstructive
sleep apnoea” OR “Obstructive sleep apnea syndrome”[TIAB] OR
“Obstructive sleep apnoea syndrome”[TIAB] OR “Obstructive sleep
apnea hypopnea syndrome”[TIAB] OR “Sleep disordered breath-
ing”[TIAB] OR “Sleep related respiratory disorder”[TIAB] OR “Sleep
respiratory disorder”[TIAB]) AND (“Oral appliance”[TIAB] OR “Oral
device”[TIAB] OR “Oral splint”[TIAB] OR “Mandibular advancement
appliance”[TIAB] OR “Mandibular advancement device”[TIAB]
OR “Mandibular advancement splint”[TIAB] OR “Dental appli-
ance”[TIAB] OR “Dental device”[TIAB] OR “Dental splint[̈TIAB] OR
“Mandibular repositioning appliance”[TIAB] OR “Mandibular repo-
sitioning device”[TIAB] OR “Mandibular repositioning splint”[TIAB]
OR “Prosthetic mandibular advancement”[TIAB] OR “Mandibular
Advancement/instrumentation[̈MeSH]) AND ((M̈eta-Analysis[̈PT]
OR m̈eta-analysis[̈TIAB]) OR (C̈ochrane Database Syst Rev[̈TA] or
s̈ystematic review[̈TIAB])). We  searched through 50 articles, and
excluded articles on pediatric subjects, treatments other than
OA, and those written in languages other than English. We also
excluded the articles, such as short communications, evidence
reports, and clinical practice guidelines. There were some Cochrane
reviews by Lim J et al., and an SR in 2006 [1] was  not searched in
this search strategy. However, we included this SR. Zhu et al. [2]
included studies on OA, but not OAm. Liu et al. [3] did not describe
the types of OA, and hence those SRs were excluded. Ultimately, 27
articles were included [1,4–29]. Descriptions of the included SRs
are shown in Table 1. In 2016, Al-Jewair et al. [30] examined the
methodological quality of the SRs and the meta-analyses (MA) on
OA therapy. They concluded that the SRs on OA therapy for adult
and pediatric sleep-disordered breathing’were conducted with an
overall acceptable methodological quality.
Breakdown of the content of the 27 SRs is as follows:
there were 10 articles on comparison with other treatments
[1,9,12,13,18–20,22,24,27], five articles on the types of OAm
[5,6,14,16,21], and six articles on the effect of OAm and the associ-
ated side effects [4,8,23,26,28,29]. There were also three articles on
predicting the therapeutic effect of OAm [10,11,15], two articles on
changes in the upper respiratory tract caused by this therapy [7,25],
and one article on a remotely controlled mandibular positioner
[17]. The SR by Okuno et al. [15] based on predicting the therapeutic
effects of OAm was the latest. They concluded that the predictive
accuracy varied depending on the definitions of treatment success
used, as well as the type of index test.
2.2. Comparison with other treatments
The SRs on comparison of OAm with other treatments always
included nasal continuous positive airway pressure (CPAP). OSA
symptoms were set as study outcomes, and these included Apnea
Hypopnea Index (AHI), Epworth Sleepiness Scale, and Quality of
Life. Cross-over studies were also included; and hence, there were
a large number of short-term studies. All the SRs stated that the
CPAP was more effective than OAm with respect to the aforemen-
tioned outcomes. Cammaroto et al. [20] concluded that CPAP still
must be considered the gold standard treatment for OSA, and OAm
may  be included in the list of alternative options. Kuhn et al. [18]
examined the Quality of Life index and commented that CPAP was
effective in achieving this outcome. They also carefully commented
that investigation with a randomized controlled trial (RCT) was
needed. Schwartz et al. [22] examined adherence, and analyzed
that the usage time of CPAP is around one hour shorter than that
of OAm. However, these results demonstrated a high degree of
heterogeneity between studies.
CPAP and OAm are the two major conservative treatment
options for OSA. We  also reached the final conclusion that CPAP is
superior to OAm in terms of improving OSA symptoms, as typified
by the AHI. There is still room to investigate adherence. It is par-
ticularly essential to monitor the adherence of patients who  have
withdrawn from CPAP therapy, when they use OAm. On  the other
hand, in clinical practice, it is important to pursue the reason why
patients are unable to use CPAP or OAm continuously, and take
action to exclude the respective causes. Good adherence can be
achieved within a few months.
2.3. Types of OAm
There are various types of OAm. OAm are broadly divided into
two types: types with upper and lower jaws separated and types
with fixed jaws. In Japan, when OA therapy is provided through
the National Health Insurance, the fixed types of OAm  are often
used to balance the costs of the technician. In this review, we
searched through five SRs on types of OAm. Ahrens investigated the
subjective patient-centered outcomes [5] and polysomnographic
indices [6]. They concluded that they were unable to demonstrate
the most effective type of OA through both investigations. Serra-
Torres et al. [14] concluded that adjustable and custom-made OAms
give better results than fixed and prefabricated appliances; and
monobloc appliances cause more adverse effects. However, this
conclusion was their interpretation of the included observational
studies. Sivaramakrishnan and Sridharan [21] compared the titrat-
able OAm with the fixed non-titratable OAm. He included five
studies. Four of the five studies were observational, and one was
a short-term cross-over randomized trial. There was a high degree
of heterogeneity between the study results, so they did not conduct
a meta-analysis. Therefore, they concluded that “This SR does not
demonstrate significant advantages in using titratable appliances”.
This field has many unresolved questions. It is essential to inves-
tigate adherence in addition to improvement of OSA symptoms,
typified by the AHI. It is also necessary to investigate the long-term
dental and skeletal side effects.
OAm positions the lower jaw anteriorly, thereby improving
upper respiratory tract obstruction. Bartolucci et al. [16] investi-
gated the anterior positioning of the lower jaw. They included RCT
data to analyze the ratio of the maximum possible distance of ante-
rior movement and improvement rate of AHI, using a bubble plot.
They concluded that the improvement in the AHI was not propor-
tional to the increase in mandibular advancement. We  also found
that the appropriate position of the lower jaw is not uniform, and
it differs depending upon the individual. However, in Japan, where
the fixed OAm (non-titratable, but adjustable OAm)  is mainstream,
it is worthwhile to provide dentists with an indication of the initial
position of the mandible.
2.4. Effect of OAm and side effects
An important outcome of OSA treatment is prevention of
complications typified by cardiovascular disease, and reducing the
mortality associated with these complications. This outcome is
more important for severe cases of OSA. Mild cases also require
caution with increase in the baseline of AHI caused by aging and
weight gain. There are two  SRs on improvement of cardiovascular
disease [8,23]. Iftikhar et al. [8] evaluated blood pressure, and
concluded that the pooled estimate shows a favorable effect of
OAm on blood pressure. However, he also stated that almost all
the data came from observational studies. Five years later, de
Vries et al. [23] evaluated the cardiovascular effects. All the RCTs
had a follow-up period of three months, which was considered to
be too short. De Vries et al. [23] also commented that one study
[31] showed that OAm was  as effective as CPAP in reducing death
from a cardiovascular cause, but that study was not an RCT, and it
probably had selection bias. We believe using a propensity score
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and conducting a long-term observational study with a carefully
designed OAm could resolve this question.
The SR by Hoekema et al. [4] was the first one on OAm. They
compared OAm with other treatments, conducted a meta-analysis
on evaluation of the type of device, and also evaluated side effects.
After that, there were no SRs published on side effects for some
time. Patients can tolerate many short-term side effects. However,
there are irreversible side effects among those that occur over the
long-term. There has been an increase in the number of studies with
longer study periods. An SR on long-term side effects has recently
been published [26,28,29]. There were differences in the number of
studies included in the three SRs. The reason for this is that Martins
et al. [28] included RCTs only. There were differences in the stud-
ies included by Araie et al. [26] and Bartolucci et al. [29] because
of the search date, and Bartolucci et al. [29] only targeted studies
where OAm was used for two or more years. The interpretation of
the studies differed among the three SRs. For example, the study
by Ringqvist et al. [32] was included as an RCT by Martins et al.
[28], and as a non-randomized study by Araie et al. [26]. However,
it was not included at all by Bartolucci et al. [29]. Either way, mor-
phological changes in the teeth and skeleton were seen over the
long-term (Araie et al. [26] stated that there were no changes in
skeletal indices or mandibular rotation). Bartolucci et al. [29] used
a bubble plot, and concluded that OAm therapy produces time-
related dental and skeletal side effects.
Araie et al. [26], stated the importance of clinicians being aware
of the side effects. We  also emphasize on the duty of dentists to
explain the long-term side effects to patients at their initial visit
to the clinic. It is vital to deal with these side effects at an early
stage. One of the long-term side effects is posterior open bite.
Reports indicate that 70% of the patients are unaware of this symp-
tom [33]. The extent of awareness of masticatory disturbances and
cosmetic disturbances caused by dental and skeletal side effects
differs depending on the patient. Dentists must respond to these
long-term side effects on a case-by-case basis. Regular persistent
follow-up monitoring is important. Among the SRs included in this
study, none investigated long-term adherence. We confirmed this
situation in our hospital and also investigated the situation in the
studies included in the SRs. In particular, we investigated the exam-
inations conducted by dentists, namely follow-up monitoring.
3. Consultation rate for follow-up: at our hospital and in
literature
3.1. Current situation in our hospital
Here we report the current situation in our hospital (Ichikawa
General Hospital, Tokyo Dental College). The dentists in this hospi-
tal have been treating patients diagnosed with OSA by the division
of otolaryngology of this hospital or another hospital with fixed
OAm since 1999. The position of the lower jaw was adjusted refer-
encing subjective symptoms or sleep tests. Follow-up monitoring
was started once the patient was free of discomfort, and the effect of
the device has been confirmed using sleep tests. The longest dura-
tion of follow-up monitoring was set as six months. The medical
consultation situation was checked every two months, and we  con-
tacted patients who had discontinued consultations by telephone.
Patients who had not had a medical consultation for one year or
more, despite repeated telephone calls, were considered to have
discontinued treatment (dropout case).
We surveyed patients who had received OAm therapy in the
one-year period between June 2015 and May  2016 (in-hospital
ethics review number: I 16–48). The consultation situation of the
patients during this period was checked up to February 2019. There
were 46 patients in total. Five patients were unable to continue use
due to inability to get used to the device or jaw pain. Two patients
discontinued treatment due to relocation, and one patient switched
to CPAP. OAm therapy was  started in the remaining 38 patients, but
eight patients stopped reporting for consultations before the sleep
test. Approximately 20% of the patients refused to undergo the test
to confirm the effect. One patient was found not to have any effect
from the sleep test. Finally, 29 patients had the effect of the treat-
ment confirmed with a sleep test, and follow-up monitoring was
started for them. Seven of these patients discontinued consulta-
tions. During the approximate three years of follow-up monitoring,
one in four patients discontinued consultations. Some patients who
discontinued consultations are still using OAm. Hence, this value is
the percentage of patients who continued consultation, and not the
percentage of those who continued to use OAm.
3.2. Consultation rate in the literature
We used the studies included in the SRs that investigated long-
term side effects [26,28,29]. Doff et al. conducted an RCT comparing
OAm with CPAP, and reported the results in multiple articles. We
checked the Flow diagram by Doff et al. [34]. Seven of the 51
patients who  switched to CPAP partway through the study; hence,
44 patients were treated with OAm. Two  patients were lost to
follow-up in the first two months, and one patient was  lost to
follow-up by the end of the study, two years later. This good result
achieved in their study demonstrates a bias of the cases participat-
ing in the RCT. We examined the prospective observational studies
included by Araie et al. [26] and Bartolucci et al. [29]. Fransson
et al. [35] reported that 12 out of 77 patients (15.6%) discontin-
ued treatment of their own accord during the two-year observation
period. Hou et al. [36] reported that 27 out of 151 patients (17.9%)
failed to attend follow-up appointments in the three-year observa-
tion period. Martínez-Gomis et al. [37] reported that nine out of 40
patients (22.5%) discontinued treatment of their own accord during
the five-year observation period. Sharples et al. [38] summarized an
investigative report on clinical effectiveness and cost-effectiveness.
This was one of the articles excluded from this review. They intro-
duced a French cohort with a 76% usage rate (not consultation rate)
over 2.75 years [39].
The aforementioned data are from the facilities that conducted
the research. We estimate that 20–25% of patients stop coming
for consultations (including patients still using the device) when
OAm therapy is continued for approximately three years in these
facilities.
4. Conclusions
4.1. Summary to date
• CPAP is superior to OA in improving OSA symptoms.
• It is necessary to survey the adherence to OAm therapy of patients
who stopped CPAP therapy.
• There is little evidence supporting the theory that OAm therapy
prevents cardiovascular disease or improves life prognosis.
• OAm therapy has dental and skeletal side effects with long-term
use.
• There is still room to investigate the types of OAm. It is partic-
ularly essential to investigate adherence and side effects after
starting follow-up monitoring (once the effect of OAm has been
confirmed).
• A certain percentage of patients discontinue consultations.
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4.2. Expectations from clinic-based dentists involved in OAm
therapy
The clear results are: superiority of CPAP and dental and skeletal
side effects of OAm. The latter is especially important for dentists.
Long-term follow-up monitoring by dentists is important to deal
with this side effects of OAm and worsening of the OSA baseline.
This review has reiterated the importance not only of long-term
use of the device by patients, but also the importance of reporting
for consultations at a medical institution, and being examined by
dentists. However, there are a certain number of patients who  hesi-
tate to visit general hospitals or dental hospitals. One of the reasons
for this is that a large number of the patients are middle-aged men
who work during the day. Clinics are easier to attend than hospitals.
We believe that providing OAm therapy in a clinic could improve
the continuing consultation rate. OAm requires adjustment when
patients are treated with dental prosthetics. From this perspective,
there are advantages in the clinic-based dentists treating patients
with OAm. The maintenance interval for periodontitis is also the
ideal interval for follow-up monitoring of OA therapy. Although
the purpose of this review was to provide the current evidence of
OAm for clinic-based dentists, this review also proves the benefit
of dental clinic-based OAm therapy.
On the other hand, the American Academy of Sleep Medicine
and the American Academy of Dental Sleep Medicine created a clin-
ical practice guideline in 2015 [40]. This clinical practice guideline
recommends that follow-up monitoring is to be continued appro-
priately by sleep physicians and qualified dentists. It is important
to foster dentists who are able to deal with sleep medicine, which
includes conducting medical examinations in collaboration with
sleep physicians. Enhancing under-graduate and post-graduate
education on sleep medicine, and establishing a specialist system
are strategies for fostering the ability of dentists to handle OAm
therapy in dental clinics. On the other hand, OAm places a burden
on the teeth and the jaws. Searching for an alternative therapy is
the duty of dentists. We  anticipate that increasing the number of
dentists involved in sleep medicine will result in the creation of
new ideas for an alternative therapy.
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